Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria
- PMID: 1929265
- PMCID: PMC284314
- DOI: 10.1128/AAC.35.6.1219
Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria
Abstract
The in vitro activities of several new beta-lactam-beta-lactamase inhibitor combinations (piperacillin plus tazobactam, ceftizoxime and cefonicid with sulbactam and clavulanic acid, and ampicillin plus 8 micrograms of sulbactam per ml) were tested with anaerobic bacteria and compared with known beta-lactam-beta-lactamase inhibitor combinations and other potent antianaerobe agents. All the combinations tested (except for the cefonicid-inhibitor combinations) were active against almost all strains of the Bacteroides fragilis group. This report indicates that beta-lactamase inhibitors may improve the activity of beta-lactam agents with marginal activity against the B. fragilis group.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
